142 related articles for article (PubMed ID: 8709180)
1. [Study on technetium-99m in radiopharmaceuticals].
Ding HJ; Yang CC
Kaohsiung J Med Sci; 1996 Mar; 12(3):132-44. PubMed ID: 8709180
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
Koźmiński P; Gniazdowska E
Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
[TBL] [Abstract][Full Text] [Related]
3. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
Tisato F; Bolzati C; Porchia M; Refosco F
Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232
[TBL] [Abstract][Full Text] [Related]
4. High--valent technetium chemistry-new opportunities for radiopharmaceutical developments.
Braband H
J Labelled Comp Radiopharm; 2014 Apr; 57(4):270-4. PubMed ID: 24347394
[TBL] [Abstract][Full Text] [Related]
5. Water-stable fac-{TcO₃}⁺ complexes - a new field of technetium chemistry.
Braband H
Chimia (Aarau); 2011; 65(10):776-81. PubMed ID: 22054130
[TBL] [Abstract][Full Text] [Related]
6. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging.
Bowen ML; Orvig C
Chem Commun (Camb); 2008 Nov; (41):5077-91. PubMed ID: 18956031
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
[TBL] [Abstract][Full Text] [Related]
8. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m radiochemistry for pharmaceutical applications.
Papagiannopoulou D
J Labelled Comp Radiopharm; 2017 Sep; 60(11):502-520. PubMed ID: 28618064
[TBL] [Abstract][Full Text] [Related]
10. Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites.
Eckelman WC; Jones AG; Duatti A; Reba RC
Drug Discov Today; 2013 Oct; 18(19-20):984-91. PubMed ID: 23806975
[TBL] [Abstract][Full Text] [Related]
11. 99m Tc-labelled chelates for nuclear medicine application. Radiopharmacy without knowledge of chemical structure?
Nakken KF
J Oslo City Hosp; 1984 Jun; 34(6):49-60. PubMed ID: 6088742
[No Abstract] [Full Text] [Related]
12. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
13. Differences between the macroscopic and tracer level chemistry of rhenium and technetium: contrasting cage isomerisation behaviour of Re(I) and Tc(I) carborane complexes.
Armstrong AF; Valliant JF
Dalton Trans; 2010 Sep; 39(35):8128-31. PubMed ID: 20694253
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of routine radiochemical quality assurance testing of technetium Tc 99m radiopharmaceuticals.
Ponto JA; Ponto LL
Am J Hosp Pharm; 1986 May; 43(5):1218-22. PubMed ID: 3087163
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary biological evaluation of the first (99m)Tc(I)-specific semi-rigid tridentate ligand based on a click chemistry strategy.
Guizani S; Malek Saied N; Picard C; Benoist E; Saidi M
J Labelled Comp Radiopharm; 2014 Mar; 57(3):158-63. PubMed ID: 24425684
[TBL] [Abstract][Full Text] [Related]
16. Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands.
Martini P; Pasquali M; Boschi A; Uccelli L; Giganti M; Duatti A
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111708
[TBL] [Abstract][Full Text] [Related]
17. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
[TBL] [Abstract][Full Text] [Related]
18. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
19. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection.
Kniess T; Laube M; Wüst F; Pietzsch J
Dalton Trans; 2017 Oct; 46(42):14435-14451. PubMed ID: 28829079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
